Transaction #25816 · Form 4 · 0001683168-25-009349

Phio Pharmaceuticals Corp. · Purchase · Common Stock, $.0001 par value

Phio Pharmaceuticals Corp. · Transacted December 23, 2025 · Filed December 29, 2025

Original SEC filing ↗

What does this filing report?

An SEC Form 4 filing for Phio Pharmaceuticals Corp. records a purchase involving Common Stock, $.0001 par value on December 23, 2025. The reported quantity was 5,000. The filing date is December 29, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.

The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.

Transaction details

Company CIK
0001533040
Security type
Non-derivative
Acquisition type
Purchase · Code P
Quantity acquired
5,000
Reported price
1.02
Reference value
5,100
Currency
Currency not specified
Ownership
Direct
Holdings after transaction
286,421
Ownership description
Not reported
SEC acceptance time
Dec 29, 2025, 8:10 AM EST
10b5-1 indication
Not indicated

Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.

Reporting owners

These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.

Company listings

PHIO · Nasdaq

This transaction is not mapped to a specific company listing.

Filing footnotes & remarks

F1
Includes shares of common stock underlying unvested restricted stock units.

Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.

This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.